2LB Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who have previously received platinum- based chemotherapy (INTEREST)
暂无分享,去创建一个
Edward S. Kim | M. Socinski | T. Mok | J. Douillard | R. Gervais | V. Hirsh | E. Lowe | L. Wu | M. Sellers | L. Li | L. Wu